@weightloss Tag

27 Aug

Posted at 12:10h in Surgical Research, Weight Research
Gastric balloons are a popular non-surgical treatment for weight loss, thanks to their effectiveness in helping patients lose weight by restricting food intake and experiencing a feeling of fullness. Although the procedure might be similar regardless of the option chosen by the patient, Spatz3 is the only gastric balloon in the market that has the possibility of adjusting its size. This proposes various benefits that make the success rate score higher than with non-adjustable gastric balloons.

WHAT IS A GASTRIC BALLOON

To understand the differences between an adjustable and non-adjustable gastric balloon, first, we need to understand how they work. A gastric balloon is made of silicone rubber that’s inserted through the mouth and placed in the stomach using an endoscope. Once it’s in the stomach, it’s filled with saline solution to take up space. Because of the lack of space around it once filled, the patient will feel satiated quicker, eat less, and therefore, lose weight. The procedure usually takes 15 minutes, and the patient can go home once the sedation wears off. The first two weeks after the procedure, the patient will be on a liquid diet and gradually transition to solid food. Usually, the healthcare professionals will offer other guidelines, such as a recommended diet or workout plan, so that the patient continues losing weight not only while the gastric balloon is inside but also after it’s been removed. Unless there is any intolerance issue, the balloon will remain in the patient’s stomach for six months. Once it’s removed, he or she is expected to continue practicing the same healthy habits to maintain the weight loss.

11 Aug

Posted at 16:31h in Pharmacology, Semaglutide
[caption id="attachment_62820" align="alignleft" width="200"]pharmacy-pills_pexels-artempodrez-4492065 Image Source[/caption] Oral Semaglutide has emerged as a significant advancement in the realm of weight loss treatments. As an alternative to traditional injectable options, oral Semaglutide offers convenience and effectiveness. This guide provides an in-depth look at oral Semaglutide, its benefits, how to access it through prescriptions, and explores compounded semaglutide online.

What is Oral Semaglutide?

Oral Semaglutide is an oral form of the medication Semaglutide, which was originally available only as an injection. It is used to manage weight loss and control blood sugar levels in individuals with obesity or type 2 diabetes.
  • Mechanism of Action: Semaglutide mimics a hormone called GLP-1, which helps regulate appetite and insulin secretion. By enhancing these processes, it can support significant weight loss and better blood sugar control.
  • Approval and Usage: The oral version is approved by the FDA for weight management and is typically prescribed as part of a comprehensive weight loss plan that includes diet and exercise.

25 Jul

Posted at 23:25h in Diabetes, Weight Research
Introduction to Tirzepatide [caption id="attachment_62575" align="alignleft" width="133"]weight controlPexels Image Source[/caption] Weight loss injections have gained significant attention over the years, with many people seeking effective solutions to combat obesity. The Tirzepatide weight loss injection is one of the latest breakthroughs in this area. But how does this new treatment differ from other weight loss injections? Let's delve into the unique characteristics and benefits of Tirzepatide compared to its counterparts. Tirzepatide has been making waves due to its impressive efficacy in promoting weight loss. Unlike traditional methods focusing solely on diet, exercise, or other medications, Tirzepatide offers a novel approach by leveraging the body's natural hormonal responses. This article aims to provide a comprehensive overview of how Tirzepatide stands out among the plethora of weight loss treatments available today.

10 Jun

Posted at 19:11h in Weight Research
Key Takeaways
  • Personalized weight management is crucial in achieving sustainable results.
  • Combined data from multiple sources enhances personalization.
  • Maintaining a relationship between providers and consumers boosts success rates.
The Need for Personalization in Weight Management Personalized weight management plans are essential in today's health-focused world, and research consistently shows their effectiveness over generic approaches. According to a study by the Centers for Disease Control and Prevention (CDC), customized weight management strategies lead to tremendous long-term success in weight loss. Additionally, platforms like BuildMyBod offer providers a turnkey solution to offer diverse services that cater to personal health needs, showing how personalization is becoming a cornerstone in weight management.

01 Feb

Posted at 11:54h in Weight Research
Bariatric surgery has a long history of proven successes. It helps to lose excess weight and empowers the individual to enjoy a fulfilling life. Losing weight is one of the prime benefits that propel people to undergo the knife. When considering Denver bariatric surgery services, patients experience other benefits. The benefits include better pain relief, cardiovascular health, hypertension, diabetes management, and mental health. When a person suffers from obesity and weight-associated health issues, bariatric surgery enhances the quality of life. Reverse Serious Diseases and Health Issues Several clinical studies show that bariatric surgery reverses long-term Type 2 diabetes. Weight loss helps lower blood cholesterol and blood sugar and reduce the risk of strokes and heart diseases. The surgery gives hope to several patients with Type 2 diabetes to stop using insulin and medications. One simple surgery reverses serious health issues and enhances overall well-being. Individuals enjoy leading more active lives by eliminating long-term health conditions. To maintain a high-quality life, patients must maintain their lifestyle to experience the benefits of bariatric surgery in the long term.

28 Aug

Posted at 16:24h in Author Interviews, Dermatology, Diabetes, Heart Disease, Weight Research
MedicalResearch.com Interview with: [caption id="attachment_60815" align="alignleft" width="150"]Dr. Alexis Elias MalavazosEndocrinology Unit Clinical Nutrition and Cardiovascular Prevention Service, IRCCS Policlinico Unit of Radiology, IRCCS Policlinico San Donato, San Donato Milanese, Italy Dr. Malavazos[/caption] Dr. Alexis Elias Malavazos Endocrinology Unit Clinical Nutrition and Cardiovascular Prevention Service, IRCCS Policlinico Unit of Radiology, IRCCS Policlinico San Donato, San Donato Milanese, Italy   MedicalResearch.com: What is the background for this study? Response: Psoriasis is a systemic inflammatory disease often associated with obesity and type-2 diabetes (T2D). The inflammatory process of psoriasis can target adipose tissue depots, particularly those surrounding the heart and the coronary arteries, exposing them to an increased risk of cardiovascular disease.

27 Apr

Posted at 16:20h in Author Interviews, Diabetes, Weight Research

Statement from Dr. Robert Gabbay, Chief Scientific and Medical Officer for the ADA, regarding the Lilly statement this of April 27, 2023. The final results of this SURMOUNT-2 study will be announced at the ADA SciSessions in June, 2023. "Tirzepatide was effective at having people with diabetes lose 15.7 % of their...

14 Apr

Posted at 19:53h in Author Interviews, Cleveland Clinic, Diabetes, JACC, Surgical Research, Weight Research
MedicalResearch.com Interview with: Amgad Mentias, MD MS FACC FESC Assistant Professor, CCLCM Section of Clinical Cardiology, Heart and Vascular Institute. Cleveland, OH 44195Amgad Mentias, MD MS FACC FESC Assistant Professor, CCLCM Section of Clinical Cardiology, Heart and Vascular Institute. Cleveland, OH 44195  MedicalResearch.com:  What is the background for this study?    Response:  There is evidence that bariatric or weight loss surgery can decrease the risk of heart attack, stroke, and death in young and middle age patients with obesity and diabetes. However, the evidence is less clear for older patients and patients without diabetes. There is also no long-term data on outcomes of bariatric surgery in the Medicare beneficiaries. So, in our study, we aimed to report long-term outcomes of bariatric surgery from a contemporary nationwide cohort from the US, while also looking into outcomes in patients older than 65 years, and patients without type 2 diabetes specifically.

11 Mar

Posted at 16:06h in Author Interviews, Endocrinology, Nutrition, Testosterone, Weight Research
MedicalResearch.com Interview with: [caption id="attachment_58866" align="alignleft" width="150"]Joe Whittaker, MSc Nutritionist MedicalResearch.com:  What is the background for this study?  Response: There are several studies showing a generational decline in men's testosterone levels, beginning in the 1970s. This is due to a variety of factors such as poorer diets, lack of physical activity, and increasing toxin exposure. Therefore, there is intense research interest in ways we can optimise testosterone levels, to combat this generational decline. Some well-known studies have found low-carbohydrate diets boost testosterone levels, but others have show the reverse effect. So, to settle the controversy we gathered and reanalysed all known studies on the topic. There was also the question of high protein diets and their effects on testosterone, which are currently disputed.   Joe Whittaker, MSc[/caption] Joe Whittaker, MSc Nutritionist MedicalResearch.com:  What is the background for this study?  Response: There are several studies showing a generational decline in men's testosterone levels, beginning in the 1970s. This is due to a variety of factors such as poorer diets, lack of physical activity, and increasing toxin exposure. Therefore, there is intense research interest in ways we can optimise testosterone levels, to combat this generational decline. Some well-known studies have found low-carbohydrate diets boost testosterone levels, but others have show the reverse effect. So, to settle the controversy we gathered and reanalysed all known studies on the topic. There was also the question of high protein diets and their effects on testosterone, which are currently disputed.

01 Aug

Posted at 15:21h in Author Interviews, COVID -19 Coronavirus, Occupational Health, Weight Research
MedicalResearch.com Interview with: https://www.newtopia.com/Jeff Ruby, JD, MBA, Founder and Chief Executive Officer Leonard Fensterheim, MPH Vice President of Analytics MedicalResearch.com: What is the background for this study? What are common weight-change findings during the pandemic?  Obesity has been linked to increased risk of serious complications and the need for costly medical utilization – all of which has been exacerbated by the COVID-19 pandemic. There has been an increase of imposed restrictions that impact healthy lifestyles – the closing of gyms as an example – leading to additional stress and the complete disruption of daily lives. It’s no surprise that many people have gained weight since the beginning of the pandemic. According to the Centers for Disease Control and Prevention (CDC), before the pandemic about 40% of Americans had obesity in the United States. This was already an alarming figure, but given that the American Psychological Association found that 42% of U.S. adults report undesired weight gain, with an average gain of 29 lbs. since the start of the pandemic, we expect that percentage has continued to grow. Against this backdrop, Newtopia sought to evaluate the impact of a guided habit change program on weight loss for 12 months during the COVID-19 pandemic. Method:
  • This was a retrospective study that looked at 1436 participants who began participating in the Newtopia experience in early 2020.
  • This analysis focused on weight change and was restricted to those participants with a body mass index >
  • 52% of participants were female, and the average age of the total study population was 46.5 years old (±10.6).
  • The percentage of participants with a 4.3% weight reduction after 12 months was assessed. This has been shown to be associated with meaningful reduction in healthcare costs.
  • The average weight loss and the percentage BMI decrease was also assessed.
  Outcomes:
  • 77% of participants lost weight.
  • 44% of participants had a weight loss of >3%.
  • Average weight loss was 4.2% (p<.0001).
  • 22% of obese participants dropped a BMI category.
Despite the challenges of the Covid-19 pandemic, individuals participating in the Newtopia habit change experience still achieved impactful weight loss.

16 May

Posted at 11:47h in Author Interviews, Diabetes, Gastrointestinal Disease, Weight Research
MedicalResearch.com Interview with: [caption id="attachment_57425" align="alignleft" width="200"]Dr. Hoff Dr. Hoff[/caption] Anna Carolina Hoff, MD Lead researcher on the study Founder and Clinical Director Angioskope Brazil São José dos Campos  MedicalResearch.com: What is the background for this study? Response: Obesity is a chronic disease that has become a global pandemic, and its prevalence continues to increase. Overweight (Body Mass Index (BMI) ≥ 27 kg/m2) and obesity (BMI ≥ 30kg/m2) lead to numerous clinical comorbidities, including metabolic, cardiovascular, oncologic, and mental health disorders. It is challenging to achieve significant and sustained weight loss with diet and lifestyle modification alone. Additionally, a reversal of obesity-related co-morbidities and improvement in quality of life entails a percent total body weight loss (%TBWL) of between 5-10%, which is rarely achieved with medications alone. The Endoscopic Sleeve Gastroplasty (ESG) results in a %TBWL between 14.6%-19.7% at 18-24 months,  and improvements in systolic blood pressure (SBP), HbA1c, and dyslipidemia at 12 months.

10 Apr

Posted at 11:15h in Author Interviews, Exercise - Fitness, Weight Research
MedicalResearch.com Interview with: [caption id="attachment_57111" align="alignleft" width="140"]Prof. Dr. Karsten Koehler Department of Sport and Health Sciences Technical University of Munich Prof. Koehler[/caption] Prof. Dr. Karsten Koehler Department of Sport and Health Sciences Technical University of Munich MedicalResearch.com: What is the background for this study? Response: The primary background is the phenomenon that most people fail to loose (meaningful) weight through exercise alone, which is related to what we call compensatory eating – an increase in food intake to compensate for the increased energy expenditure of exercise. This is been described in a number of studies and is considered a key weight loss barrier – yet few have come up with solutions to overcome this problem. Therefore, we wanted to see if the timing of food choices has an impact on how much and what we want to eat in the context of exercise.